Trials / Conditions / Donor Lymphocyte Infusion
Donor Lymphocyte Infusion
4 registered clinical trials studyying Donor Lymphocyte Infusion — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignanc NCT03771222 | Chinese PLA General Hospital | Phase 2 |
| Recruiting | Exercise as an Immune Adjuvant for Allogeneic Cell Therapies NCT06643221 | University of Arizona | EARLY_Phase 1 |
| Unknown | Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotrans NCT03297528 | Peking University People's Hospital | Phase 2 |
| Completed | MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT NCT02673008 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |